104 related articles for article (PubMed ID: 23757927)
1. The influence of conjugates on their functionality in the therapy of solid tumors.
Osadnik KM; Jelonek K
Acta Pol Pharm; 2013; 70(3):379-86. PubMed ID: 23757927
[TBL] [Abstract][Full Text] [Related]
2. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
Maeda H; Bharate GY; Daruwalla J
Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
[TBL] [Abstract][Full Text] [Related]
3. Exploiting the enhanced permeability and retention effect for tumor targeting.
Iyer AK; Khaled G; Fang J; Maeda H
Drug Discov Today; 2006 Sep; 11(17-18):812-8. PubMed ID: 16935749
[TBL] [Abstract][Full Text] [Related]
4. [Targeting of anti-cancer drugs with nano-sized carrier system].
Yokoyama M; Okano T
Nihon Rinsho; 1998 Dec; 56(12):3227-34. PubMed ID: 9883646
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).
Tanaka T; Shiramoto S; Miyashita M; Fujishima Y; Kaneo Y
Int J Pharm; 2004 Jun; 277(1-2):39-61. PubMed ID: 15158968
[TBL] [Abstract][Full Text] [Related]
6. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
Hamad I; Moghimi SM
Expert Opin Drug Deliv; 2008 Feb; 5(2):205-19. PubMed ID: 18248319
[TBL] [Abstract][Full Text] [Related]
7. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.
Maeda H
J Control Release; 2012 Dec; 164(2):138-44. PubMed ID: 22595146
[TBL] [Abstract][Full Text] [Related]
8. Advances in polymeric micelles for drug delivery and tumor targeting.
Kedar U; Phutane P; Shidhaye S; Kadam V
Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
[TBL] [Abstract][Full Text] [Related]
9. Polymeric drug delivery systems for localized cancer chemotherapy.
De Souza R; Zahedi P; Allen CJ; Piquette-Miller M
Drug Deliv; 2010 Aug; 17(6):365-75. PubMed ID: 20429844
[TBL] [Abstract][Full Text] [Related]
10. Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP
Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K
Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the study of tumor pH-responsive polymeric micelles for cancer drug targeting delivery].
Xu JX; Tang JB; Zhao LH; Shen YQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1328-35. PubMed ID: 21351464
[TBL] [Abstract][Full Text] [Related]
13. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials.
Yokoyama M
Expert Opin Drug Deliv; 2010 Feb; 7(2):145-58. PubMed ID: 20095939
[TBL] [Abstract][Full Text] [Related]
14. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects.
Maruyama K
Adv Drug Deliv Rev; 2011 Mar; 63(3):161-9. PubMed ID: 20869415
[TBL] [Abstract][Full Text] [Related]
15. Polymer-protein and polymer-drug conjugates in cancer therapy.
Thanou M; Duncan R
Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
[TBL] [Abstract][Full Text] [Related]
16. Extravasation of polymeric nanomedicines across tumor vasculature.
Danquah MK; Zhang XA; Mahato RI
Adv Drug Deliv Rev; 2011 Jul; 63(8):623-39. PubMed ID: 21144874
[TBL] [Abstract][Full Text] [Related]
17. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.
Maeda H
Bioconjug Chem; 2010 May; 21(5):797-802. PubMed ID: 20397686
[TBL] [Abstract][Full Text] [Related]
18. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.
Greish K
Methods Mol Biol; 2010; 624():25-37. PubMed ID: 20217587
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
20. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity.
Maeda H
Adv Drug Deliv Rev; 2015 Aug; 91():3-6. PubMed ID: 25579058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
